Millions in the developing world depend on affordable generic medicines. As multinational pharmaceutical companies pursue strategies to protect patents for key drugs in India and Brazil, access to essential medicines is frustrated and concerns regarding the rising cost of life-saving drugs intensify. [with sections on "Business Impacts on Human Rights"; "Demanding Justice"; and "Human Rights Defenders"]